EML4-ALK gene fusion is initiated by inversion in the short arm of chromosome 2, which juxtaposes the N-terminal of the EML4 promoter and the kinase domain of the ALK gene, ultimately leading to ligand-independent constitutive activation of ALK and promoting cancer cell proliferation and survival. This evidence concerns the gene EML4 and cancer.